Phase 3 Ovarian Cancer Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Polycystic Ovary Syndrome (PCOS), confirmed using the 2023 international PCOS guidelines
- You are between 18 and 37 years old
- Your Body Mass Index (BMI) is 25 or above but below 40 (this means you are in the overweight or obese range)
- You are willing to follow the trial procedures and have signed an agreement to take part
- You can read and communicate well enough in Finnish or Swedish
Who may not be able to join:
- You do not have a confirmed PCOS diagnosis based on the 2023 international PCOS guidelines
- You have used hormonal contraception (such as the pill, patch, or hormonal coil) in the last 3 months
- You are currently pregnant
- You are currently breastfeeding
- You have diabetes that is not being treated
- You have an underactive thyroid (hypothyroidism)
- You have higher-than-normal levels of a hormone called prolactin (hyperprolactinemia)
- You currently take medication for diabetes
- You currently take medication for high cholesterol
- You currently take medication for obesity or weight management
- You currently take cortisone tablets or other oral cortisone-based medication
- You have had a bad reaction or allergy to a medicine called metformin
- You have a condition called acute metabolic acidosis, where acid builds up in the body (confirm with trial site)
- You have kidney problems or reduced kidney function
- You have liver problems or reduced liver function
- You have heart failure or serious breathing/lung problems
- You have a serious mental health condition
- You have problems with alcohol dependency
- You work at the clinic running this trial, or are a close family member of someone who does
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Weight; Homeostatic model assessment for insulin resistance (HOMA-IR); Hirsutism; Total testosterone; Appearance of severe of adverse effects; Anti-Mullerian hormone (AMH)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.